Jump to section
Linus Health’s mission is to make brain health accessible for everyone by transforming the way we measure, monitor, and maintain brain function.
Few candidates hear
back within 2 weeks
21% employee growth in 12 months
Alzheimer's is now the sixth highest cause of death in the US, and the number of people with the disease is on the rise in tandem with the country’s aging population. It’s also an extremely costly illness due in large part to direct care requirements. However, Azheimer's can be present up to 20 years before symptoms arise, and if caught early can be treated far more effectively.
Linus Health's digital Alzheimer's screening platform offers doctors a quick, user-friendly test for cognitive health. Its AI-powered assessments analyze performance on the company’s scientifically validated test and draws out insights based on performance that would be difficult to detect with the human eye. Further adding value, the platform also automates numerous workflows around neurological diagnostics , cutting hours per week of manual administration.
Given the rising severity of the situation - 140 million people worldwide are projected to have dementia by 2050 -, Linus’ rapid growth and impressive fundraising since its 2019 launch makes sense. The company is continuing to develop its product and scale its adoption globally as it positions itself as a key player in the fight against Alzheimer's.
Freddie
Company Specialist at Welcome to the Jungle
Dr. David Bates
(CEO)Was a founding partner of Tamarisc Ventures, and co-founded Bode, a tech-enabled hospitality company for group travel. Previously held positions at Morningside Ventures, F-Wave, Harvard Medical School, Massachusetts General Hospital, University of Louisville, and Georgia Tech.